| Biomarker ID | 1029 |
| PMID | 23231923 |
| Year | 2012 |
| Biomarker | miR-30d |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in PCa Cell Lines (> 2 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- transcription by RNA polymerase II; regulation of transcription by RNA polymerase II; Gene expression (Transcription); cellular protein modification process; protein modification process |
| Experiment | Normal Vs Cancerous Prostate Cell Lines |
| Type of Biomarker | Diagnostic |
| Cohort | Normal human prostate cell lines (epithelial cells, RWPE-1; stromal cells, PrSc), cancer cell lines (LNCaP, PC-3, and DU145) were used |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | miR-30d |